Protara Therapeutics, Inc. (TARA)

NASDAQ: TARA · Real-Time Price · USD

3.940

+0.050 (1.29%)

At close: Aug 13, 2026, 4:00 PM EDT

3.940

0.00 (0.00%)

After-hours: Aug 13, 2026, 4:10 PM EDT

Protara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.08	49.66	162.8	39.59	24.13	35.72
Short-Term Investments	125.42	105.9	7.49	25.99	60.24	55.51
Cash & Short-Term Investments	142.49	155.55	170.29	65.58	84.37	91.23
Cash Growth	16.59%	-8.65%	159.67%	-22.27%	-7.52%	-45.89%
Other Current Assets	3.66	3.95	1.86	3.13	1.78	1.88
Total Current Assets	146.15	159.5	172.16	68.71	86.15	93.11
Net Property, Plant & Equipment	3.92	3.93	5.28	6.56	7.87	8.89
Goodwill	-	-	-	-	-	29.52
Long-Term Investments	19.36	42.34	-	-	17.89	39.47
Other Long-Term Assets	6.67	3.7	4.02	3.69	1.39	1.61
Total Assets	176.09	209.47	181.45	78.95	113.29	172.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.66	3.47	4.43	2.43	1.59	0.95
Accrued Expenses	7.37	6.23	5.41	2.73	3.24	2.49
Current Portion of Leases	1.29	1.24	1.12	0.98	0.92	0.86
Total Current Liabilities	13.32	10.94	10.96	6.15	5.74	4.3
Long-Term Leases	1.46	2.12	3.36	4.48	5.47	6.38
Total Long-Term Liabilities	1.46	2.12	3.36	4.48	5.47	6.38
Total Liabilities	14.78	13.06	14.32	10.63	11.21	10.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Shareholders' Equity	161.31	196.41	167.13	68.32	102.08	161.91
Total Liabilities & Equity	176.09	209.47	181.45	78.95	113.29	172.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.75	3.36	4.48	5.47	6.38	7.24
Net Cash (Debt)	139.75	152.2	165.81	60.11	77.99	83.99
Net Cash Growth	18.16%	-8.21%	175.83%	-22.92%	-7.15%	-49.86%
Net Cash Per Share	2.70	3.55	8.05	5.30	6.93	7.48
Book Value	161.31	196.41	167.13	68.32	102.08	161.91
Book Value Per Share	3.12	4.59	8.12	6.03	9.07	14.41
Tangible Book Value	161.31	196.41	167.13	68.32	102.08	132.4
Tangible Book Value Per Share	3.12	4.59	8.12	6.03	9.07	11.79

SEC Filings: 10-K · 10-Q